| 000 | 01389 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513050856.0 | ||
| 264 | 0 | _c19950425 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1994.tb04374.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeifert, R D | |
| 245 | 0 | 0 |
_aPharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cNov 1994 |
||
| 300 |
_a405-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aDidanosine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Seropositivity _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 |
_aStavudine _xadministration & dosage |
| 700 | 1 | _aStewart, M B | |
| 700 | 1 | _aSramek, J J | |
| 700 | 1 | _aConrad, J | |
| 700 | 1 | _aKaul, S | |
| 700 | 1 | _aCutler, N R | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 38 _gno. 5 _gp. 405-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1994.tb04374.x _zAvailable from publisher's website |
| 999 |
_c7892908 _d7892908 |
||